½ÃÀ庸°í¼­
»óǰÄÚµå
1596265

·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå : ±â¼ú À¯Çü, ±¸¼º ¿ä¼Ò, ÀÀ¿ë ºÐ¾ß, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Robotic Ureteroscopy Market by Technology Type, Components, Application, End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 190 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀåÀº 2023³â¿¡ 5¾ï 1,829¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 5¾ï 9,893¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 16.14%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 14¾ï 7,782¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

·Îº¿ ¿ä°ü°æ °Ë»ç´Â ¿ä°ü°æ °Ë»ç(¿ä°ü°æÀ» ÀÌ¿ëÇØ ¿ä·Î ³» »óŸ¦ Áø´ÜÇϰí Ä¡·áÇÏ´Â °úÁ¤)¸¦ ¼öÇàÇϱâ À§ÇØ ·Îº¿ ±â¼úÀ» ÀÌ¿ëÇÑ Æ¯¼ö ÀÇ·á ½Ã¼úÀÔ´Ï´Ù. ÃÖ¼Ò Ä§½À ¼ö¼úÀÇ ¹ßÀüÀ¸·Î ±× ¹üÀ§°¡ ºü¸£°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. ·Îº¿ ¿ä°ü°æ °Ë»çÀÇ Çʿ伺Àº ÁÖ·Î ¿ä·Î °á¼®, Á¾¾ç, ÇùÂøÀ» ´Ù·ç´Â ¼ö¼úÀÇ Á¤È®¼º°ú ȯÀÚÀÇ È¸º¹ ½Ã°£ ´ÜÃàÀÇ Çʿ伺¿¡¼­ ºñ·ÔµË´Ï´Ù. ƯÈ÷ º¹ÀâÇÏ°í ¼¶¼¼ÇÑ ¼ö¼úÀÇ °æ¿ì Á¤È®µµ°¡ °¡Àå Áß¿äÇϸç ÇÕº´ÁõÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àû¿ë ¹üÀ§´Â º´¿ø°ú Àü¹® Ŭ¸®´ÐÀÇ ºñ´¢±â°ú¿¡ Àû¿ëµÇ¸ç, ÃÖÁ¾ ¿ëµµ´Â Áø´Ü°ú Ä¡·á ¸ðµÎ¿¡ Àû¿ëµË´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 5¾ï 1,829¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 5¾ï 9,893¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 14¾ï 7,782¸¸ ´Þ·¯
CAGR(%) 16.14%

½ÃÀå ÀλçÀÌÆ®¿¡ µû¸£¸é ºñ´¢±â°ú Áúȯ Áõ°¡, ·Îº¿ °øÇÐÀÇ ±â¼ú ¹ßÀü, ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡°¡ ·Îº¿ ¿ä°ü°æ °Ë»ç ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ²ÅÈü´Ï´Ù. ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ Àü ¼¼°èÀûÀÎ ÅõÀÚ Áõ°¡µµ ½ÃÀå °³Ã´À» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀáÀçÀûÀÎ ºñÁî´Ï½º ±âȸ´Â ºñ´¢±â°úÀû °³ÀÔÀÌ ÇÊ¿äÇÑ °í·ÉÈ­ Àα¸ Áõ°¡¿¡ ÀÖÀ¸¸ç, ÀÌ´Â ´ë±Ô¸ð ȯÀÚÃþÀ» Á¦½ÃÇÕ´Ï´Ù. ¶ÇÇÑ, ±â¼ú °³¹ßÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü °£ÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀº äÅÃÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ ½ÃÀåÀº ³ôÀº Àåºñ ºñ¿ë, Á¦ÇÑµÈ ¼÷·ÃµÈ ÀηÂÀÇ °¡¿ë¼º, ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ´Â ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í °°Àº °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù.

ÀÌ ºÐ¾ßÀÇ ±â¼ú Çõ½ÅÀº ·Îº¿ ½Ã½ºÅÛÀÇ ÀΰøÁö´ÉÀ» °­È­ÇÏ¿© ¼ö¼úÀÇ ¼º°ú¿Í È¿À²¼ºÀ» Çâ»ó½ÃŰ´Â µ¥ ÁßÁ¡À» µÑ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀåºñÀÇ ºñ¿ë È¿À²¼ºÀ» ³ôÀÏ ¼ö ÀÖ´Â ½Å¼ÒÀç¿¡ ´ëÇÑ ¿¬±¸µµ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ½ÃÀåÀº ¿ªµ¿ÀûÀÌ°í ±â¼úÀûÀ¸·Î ²÷ÀÓ¾øÀÌ º¯È­Çϰí Àֱ⠶§¹®¿¡ ±â¾÷Àº ±â¼ú Çõ½Å°ú ±ÔÁ¦ º¯°æ¿¡ ¹ÎøÇÏ°Ô ´ëÀÀÇØ¾ß ÇÕ´Ï´Ù. ¸¶Áö¸·À¸·Î, ¼÷·ÃµÈ ÀÛ¾÷ÀÚ Ç®À» È®´ëÇϱâ À§ÇÑ ±³À° ÇÁ·Î±×·¥¿¡ ÁýÁßÇÔÀ¸·Î½á ½ÃÀå ħÅõ¸¦ ´õ¿í °­È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀ» Ÿ°ÙÀ¸·Î ÇÑ Àü·«À¸·Î ´ëÀÀÇÏ¸é ±Þ¼ºÀåÇÏ´Â ÇコÄÉ¾î ºÐ¾ß¿¡¼­ Å« ½ÃÀå Á¡À¯À²À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÅÀå °á¼® ¹× ºñ´¢±â ÁúȯÀÇ À¯º´·ü Áõ°¡
    • Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • ÷´Ü ÀÇ·á±â±â »ç¿ë¿¡ ´ëÇÑ Á¤ºÎÀÇ ÅõÀÚ ¹× Áö¿ø
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ·Îº¿ ¿ä°ü°æ °Ë»ç¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • º¸´Ù Áøº¸µÇ°í ºñ¿ë È¿À²ÀûÀÎ ·Îº¿ ¼Ö·ç¼Ç °³¹ßÀ» À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß ³ë·Â
    • »õ·Î¿î ·Îº¿ ¿ä°ü°æ °Ë»ç ÀåÄ¡ ½ÂÀÎ Áõ°¡
  • ½ÃÀå °úÁ¦
    • ·Îº¿ ¿ä°ü°æ °Ë»çÀÇ ÇÕº´Áõ°ú ÇѰè

Portre's Five Forces: ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀåÀ» Ž»öÇÏ´Â Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â µ¥ Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå¿¡ ´ëÇÑ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå¿¡¼­ÀÇ ¼º°ø °æ·Î¸¦ ±×¸³´Ï´Ù.

·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå : ±â¼ú À¯Çüº°

  • ¿ÏÀü ÀÚÀ²Çü ·Îº¿ ¿ä°ü°æ °Ë»ç
  • ¿ø°Ý Á¦¾î ·Îº¿ ¿ä°ü°æ °Ë»ç
  • ¹ÝÀÚÀ²Çü ·Îº¿ ¿ä°ü°æ °Ë»ç

Á¦7Àå ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ÄÁÆ®·Ñ ÄܼÖ
  • Ç÷º¼­ºí ¿ä°ü°æ
  • À̹Ì¡ ½Ã½ºÅÛ
  • ·Îº¿ ¾Ï

Á¦8Àå ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå : ¿ëµµº°

  • ½ÅÀå°á¼® Á¦°Å
  • Á¾¾ç ÀýÁ¦

Á¦9Àå ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • Àü¹® Ŭ¸®´Ð

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ·Îº¿ ¿ä°ü°æ °Ë»ç ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CMR Surgical Ltd.
  • ELMED Medical Systems
  • Ethicon by Johnson & Johnson Services, Inc.
  • FUJIFILM Holdings America Corporation
  • International Medical Lasers
  • Intuitive Surgical, Inc.
  • Medtronic PLC
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers AG
  • STERIS PLC
  • Stryker Corporation
  • The Urology Group
LSH

The Robotic Ureteroscopy Market was valued at USD 518.29 million in 2023, expected to reach USD 598.93 million in 2024, and is projected to grow at a CAGR of 16.14%, to USD 1,477.82 million by 2030.

Robotic ureteroscopy is a specialized medical procedure using robotic technology to perform ureteroscopy-a process that involves diagnosing and treating conditions within the urinary tract using a ureteroscope. Its scope is rapidly increasing, thanks to advances in minimally invasive surgery. The necessity for robotic ureteroscopy arises primarily from the need for precision and reduced patient recovery time in procedures addressing urinary stones, tumors, and strictures. It is particularly beneficial in complex and delicate surgeries where precision is paramount, significantly minimizing complications. The application scope extends to urology departments in hospitals and specialized clinics, and its end-use spans both diagnostic and therapeutic purposes.

KEY MARKET STATISTICS
Base Year [2023] USD 518.29 million
Estimated Year [2024] USD 598.93 million
Forecast Year [2030] USD 1,477.82 million
CAGR (%) 16.14%

Market insights suggest that growing incidences of urological disorders, coupled with technological advancements in robotics and increasing preference for minimally invasive procedures, are key factors influencing the growth of robotic ureteroscopy. The heightened global investment in healthcare infrastructure is also propelling market development. A potential opportunity lies in the expanding aging population that may require urological interventions, presenting a large patient demographic. Furthermore, strategic partnerships between technology developers and healthcare providers could drive adoption. Nevertheless, the market faces challenges such as high equipment cost, limited availability of skilled personnel, and strict regulatory frameworks that may inhibit growth.

Innovation in this field could focus on enhancing artificial intelligence in robotic systems to improve procedural outcomes and efficiency. Researching new materials that make the equipment more cost-effective could also be pivotal. The market is dynamic, with constant technological shifts; therefore, players should remain agile to adapt to innovations and regulatory changes. Ultimately, focusing on training programs to expand the pool of skilled operators can further bolster market penetration. Addressing these factors with targeted strategies can position businesses to capture significant market share in this burgeoning healthcare segment.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Robotic Ureteroscopy Market

The Robotic Ureteroscopy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of kidney stones and urological conditions
    • Growing demand for minimally invasive surgery
    • Government investment and support for use of advance healthcare devices
  • Market Restraints
    • High cost associated with robotic ureteroscopy
  • Market Opportunities
    • Ongoing R&D efforts for the development of more advanced and cost-effective robotic solutions
    • Increasing approvals for new robotic ureteroscopy devices
  • Market Challenges
    • Complications and limitations of robotic ureteroscopy

Porter's Five Forces: A Strategic Tool for Navigating the Robotic Ureteroscopy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Robotic Ureteroscopy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Robotic Ureteroscopy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Robotic Ureteroscopy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Robotic Ureteroscopy Market

A detailed market share analysis in the Robotic Ureteroscopy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Robotic Ureteroscopy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Robotic Ureteroscopy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Robotic Ureteroscopy Market

A strategic analysis of the Robotic Ureteroscopy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Robotic Ureteroscopy Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Boston Scientific Corporation, CMR Surgical Ltd., ELMED Medical Systems, Ethicon by Johnson & Johnson Services, Inc., FUJIFILM Holdings America Corporation, International Medical Lasers, Intuitive Surgical, Inc., Medtronic PLC, Olympus Corporation, Richard Wolf GmbH, Siemens Healthineers AG, STERIS PLC, Stryker Corporation, and The Urology Group.

Market Segmentation & Coverage

This research report categorizes the Robotic Ureteroscopy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology Type, market is studied across Fully Autonomous Robotic Ureteroscopy, Remote Control Robotic Ureteroscopy, and Semi-Autonomous Robotic Ureteroscopy.
  • Based on Components, market is studied across Control Console, Flexible Ureteroscope, Imaging System, and Robotic Arm.
  • Based on Application, market is studied across Kidney Stone Removal and Tumor Resection.
  • Based on End User, market is studied across Hospitals and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of kidney stones and urological conditions
      • 5.1.1.2. Growing demand for minimally invasive surgery
      • 5.1.1.3. Government investment and support for use of advance healthcare devices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with robotic ureteroscopy
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D efforts for the development of more advanced and cost-effective robotic solutions
      • 5.1.3.2. Increasing approvals for new robotic ureteroscopy devices
    • 5.1.4. Challenges
      • 5.1.4.1. Complications and limitations of robotic ureteroscopy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Robotic Ureteroscopy Market, by Technology Type

  • 6.1. Introduction
  • 6.2. Fully Autonomous Robotic Ureteroscopy
  • 6.3. Remote Control Robotic Ureteroscopy
  • 6.4. Semi-Autonomous Robotic Ureteroscopy

7. Robotic Ureteroscopy Market, by Components

  • 7.1. Introduction
  • 7.2. Control Console
  • 7.3. Flexible Ureteroscope
  • 7.4. Imaging System
  • 7.5. Robotic Arm

8. Robotic Ureteroscopy Market, by Application

  • 8.1. Introduction
  • 8.2. Kidney Stone Removal
  • 8.3. Tumor Resection

9. Robotic Ureteroscopy Market, by End User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Specialty Clinics

10. Americas Robotic Ureteroscopy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Robotic Ureteroscopy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Robotic Ureteroscopy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Becton, Dickinson and Company
  • 2. Boston Scientific Corporation
  • 3. CMR Surgical Ltd.
  • 4. ELMED Medical Systems
  • 5. Ethicon by Johnson & Johnson Services, Inc.
  • 6. FUJIFILM Holdings America Corporation
  • 7. International Medical Lasers
  • 8. Intuitive Surgical, Inc.
  • 9. Medtronic PLC
  • 10. Olympus Corporation
  • 11. Richard Wolf GmbH
  • 12. Siemens Healthineers AG
  • 13. STERIS PLC
  • 14. Stryker Corporation
  • 15. The Urology Group
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦